Mediastinal radiotherapy after adjuvant chemotherapy for resected non–small cell lung cancer with N2 lymphadenopathy: A novel meta-analysisCentral MessagePerspective

Mediastinal radiotherapy after adjuvant chemotherapy for resected non–small cell lung cancer with N2 lymphadenopathy: A novel meta-analysisCentral MessagePerspective

Introduction: Treatment for stage IIIA N2 non–small cell lung cancer (NSCLC) typically involves a combination of chemotherapy, radiotherapy, and surgery, but the optimal sequencing is not determined. Local recurrence rates following surgery remain high, and the role of postoperative radiotherapy (PO...

Full description

Bibliographic Details
Main Authors: Leanne Harling, PhD, FRCS, Shruti Jayakumar, MBBS, Hutan Ashrafian, PhD, MRCS, Andrea Bille, MD PhD, Levon Toufektzian, MD, PhD, FEBTS, Dan Smith, FRCR
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:JTCVS Open
Subjects:
radiotherapy
thoracic surgery
non–small cell lung cancer
lung cancer chemotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S266627362030200X

Internet

http://www.sciencedirect.com/science/article/pii/S266627362030200X

Similar Items